- Hey, I'm Rebecca Gordon.
- I'm Sylvia Gordon.
We're going to start off talking what happened
with our alternative to AHIP called NAHU
and when testing is open for this AEP,
which is soon.
- Soon. Stay tuned.
(upbeat pop music)
- All right, so it was just a year ago,
or maybe more than that.
- No, it was like two years ago.
We've been working on this a long time.
- You were on the board with all our other
big-wig colleagues and you guys were going back
because AHIP was such a colossal mess. Right?
- Right.
So, two years ago, a lot of people lost their renewals
because they couldn't pass it in two attempts.
- It was horrible.
- It was a dud test, and then they lost their renewals.
- Yeah, and so you guys like hey,
you're going to create something through NAHU,
our voice, our insurance voice,
and make it way more agent friendly. Correct?
- Right, National Association of Health Underwriters.
So, a whole bunch of us FMOs came together
to build a better test.
- And you did.
- And we did.
We built a better test.
We made it cheaper, and we gave CE with it.
- [Rebecca] Way better.
It's just a whole better opportunity
for agents to actually learn something.
Plus a lot more attempts to take it,
and, of course, we met with resistance from AHIP, right?
- Right, because we're taking away
their market share.
- Right.
So, I don't know what happened,
but we got all the carriers to accept it.
All the big carriers except.
- I'm not saying their names.
- Except UnitedHealthcare and Aetna.
So UnitedHealthcare and Aetna
hurt the whole agent world by this
because now you can't really take,
people aren't gonna want to take two.
Unless you're only selling for Anthem,
you could go in and take NAHU instead of AHIP,
but most people sell for a variety,
so they're really hurting us.
So, not happy.
Not showing great leadership there.
- The fight isn't over.
- United and Aetna, yeah.
So we're hoping with the voice from the field
that we can get this because the money will then
go to National Association of Health Underwriters
to help advance causes.
- For us.
- For agents.
It's our money going into this and so
we're not across the finish line yet,
not for lack of trying from a lot of FMOs in the field.
But AHIP is open,
and for most people, that's going to be their only choice.
Because we've worked so hard with this with NAHU,
competition makes everybody better.
- I love competition.
That keeps it interesting.
- AHIP, AHIP, they copied everything.
They did a price break.
They did CE, they did other stuff.
They give you more chances to take it.
I don't know if their test is better yet
because I haven't taken it yet
to see if it's still the same old crap.
But, AHIP is open.
- Now, you don't want to do it on the 21st, do ya?
- No, because a lot of agents, younger agents,
they get confused, so they're just like,
"I want to get this done."
- Sure, I'd be like that.
- And then later they figure out they didn't
get the discount, and they're trying to get that.
You have to go in through a carrier portal.
That's something everybody knows
that's been in this for a while.
But if you're new, you have new agents,
make sure they don't try to jump the gun.
- By going through a carrier portal,
you get a discounted rate.
So even though it's opened up June 21st,
you want to wait until the carriers are open,
go in through their site and get a $50
reduction in price.
- OK.
- And that makes sense.
- New great news here on our enrollment tool.
- Oh, yeah we've had a lot of success
with these enrollment tools.
So yeah, you're gonna talk about
the provider lookups, very exciting.
- No, you're going to talk about the provider lookup.
- No I'm not, this is what you're supposed to talk about.
- So the provider lookup will save you a lot of time
because you'll be able to go in and look up providers.
- (laughs)
- A lot of people still aren't using electronic.
- That's awesome.
- Yeah, so check out my enrollment tool.
There's lots of trainings going on right now.
It is Connecture, it is Connecture.
If somebody's telling you you've got to move your contract
from us to them because they have this things,
they all have the same thing.
All the FMOs have the same thing.
- I do love the names.
- Right, everybody branded it their own name.
It's Connecture or Sunfire.
We have both. You have access to both, boom.
Let's talk about this Alzheimer's drug.
- Ooh, yeah.
- I don't know how to pronounce it.
- And I tried to look it up.
- Adahalum, Adulahim.
- Aduhelm.
- So this drug is rocking the Medicare world
because it's so expensive.
- And it showing positive results.
- It's, eh, no, I think that's part of the controversy,
is that it does not definitively show that it works.
So that's why people are saying
it's got emergency approval,
but it does not show that it necessarily works.
- Like a (indecipherable).
- But go spend $56,000 a year on it
and then let's see if it works.
So since there's six million people on Alzheimer's,
people are hopeful.
However, the cost of it is insane.
- Yeah.
If you look at all of these top drugs,
you can see this one is between six and 29 billion.
However, as this population continues to age,
as more seniors age in,
this is projected to cost over a trillion dollars,
so that's gonna have a huge impact on your Part Bs.
Because, how is this administered?
- So, it's administered in the doctor's office.
It is an infusion like the other most expensive drugs
that we showed.
So Eliquis, Keytruda, Januvia,
you know these drugs that are so expensive right here.
And this is what it costs Medicare a year.
Xarelto, four billion,
and it's funny how familiar we are
with the names of these drugs
because these are the hard,
these are the one drug that makes the whole decision
on what Med Advantage to go with
or what Part D to go with.
So, the problem with these drugs
being infusions in doctor's office,
they don't come out of Part D.
- It comes out of Part B.
- It's in the doctor's office.
It's an infusion in the doctor's office.
So, if it's in the doctor's office, it's Part B.
- And you're Part B is gonna go up.
- Right, where's this cost gonna come from?
Okay, so Part B is gonna go up anyway
because of this inflation.
- [Rebecca] Right.
- So we're expecting,
they already said we expect
cost of living for Social Security
to go up 5.3%,
which is the highest since 2007, something crazy.
So we already are bracing
for a really high inflated.
- What's that going to do to the market overall?
How will that happen in response to
Med Sup or Advantage plans?
What do you think the people will do
facing this much inflation on these policies?
- So, because of this one drug
and this huge elephant cost,
Med Sup companies have to respond right now.
They have to adjust their pricing.
So Med Sup prices are going to go way up
because of this drug.
In which people are going to run to Med Advantage.
- Yep.
- But on Med Advantage,
they still can't run away from it.
- Because they'll have the 20%.
- They'll still have the 20%,
which they said that could cost somebody
that you're gonna hit your max.
So the carriers have to respond on that side too.
The bottom line is,
you're gonna pay more for Part B.
You're gonna pay more for your deductible.
- It's all going up.
- You're gonna pay more for your Med.
Everything is gonna cost more because of this drug
that they don't know if it even works yet.
- [Rebecca] Stay tuned.
- If it does work,
I think everybody would say this is probably
really good news.
Anybody who's ever had somebody
in their family with Alzheimer's
and it's just so bleak,
but we don't know if it even works.
- Well said.
- Adulheim, so we'll wait and see right now.
- Stay tuned on that.
- Yeah, so that's kind of depressing.
How about we end on something positive?
- So, on Great News, our partner's Humana,
they do a fantastic job in this market,
they have come out,
or I should say they're going back to old school.
They have something called dispatch health,
which is for our clients.
They will send someone to their homes
for urgent care related items
like COVID, head injuries.
- Anxiety.
- Shingles.
- And I love this, and more.
- So they're gonna send a nurse or nurse.
- A nurse practitioner.
- To your house.
- To your house. That is fantastic.
It's in select cities, select states.
So, who do we have?
- So, it is in Indianapolis.
It is in Boise.
It's in Atlanta, Colorado Springs, Cleveland,
Las Vegas, Moorestown, New Jersey,
Oklahoma City, Portland, Nashville, Knoxville,
and like all the big cities in Texas,
Richmond, and all the big cities in Washington State.
- You know, why would they be going to Boise?
- Humana is expanded into Idaho.
- Well, and also, last year I remember them saying
that Idaho was becoming the number one state
for seniors to flock to.
- Yeah, so something like 3,000 people a month
are moving out of California into Idaho.
- Idaho is just really attracting.
- Yeah, because people can't afford
to live in California or Oregon.
So this dispatch health,
hopefully the other carriers,
they all copy the good things.
And this makes sense.
- This makes a ton of sense.
- And we're excited about that.
We're going to end this show on a high note,
so look out for that if you are in those markets
with Humana.
- Good selling. Talk to you soon.
(upbeat pop music)